Immunotherapy Better Than Cryotherapy for Wart Lesions

Share this content:
Immunotherapy Better Than Cryotherapy for Wart Lesions
Immunotherapy Better Than Cryotherapy for Wart Lesions

FRIDAY, Feb. 3, 2017 (HealthDay News) -- Intralesional immunotherapy is more effective than cryotherapy for treatment of wart lesions, according to a study published online Jan. 21 in the International Journal of Dermatology.

Fahime Khozeimeh, M.D., from the Mashhad University of Medical Sciences in Iran, and colleagues compared the efficacy of immunotherapy and cryotherapy on wart lesions among 60 patients with verruca vulgaris and plantar warts. The patients were randomly divided into two groups: One received intralesional injection of candida antigen repeated every three weeks until complete improvement or a maximum of three sessions, and the other group received cryotherapy with liquid nitrogen for a maximum of 10 sessions or until lesion clearance.

The researchers found that the patients exhibited a significant therapeutic response to immunotherapy versus cryotherapy (P = 0.023). For both groups there was a significant difference between the time-elapsed before treatment and the therapeutic response (P = 0.041). Overall, 76.7 and 56.7 percent of patients were completely cured by immunotherapy and responded to cryotherapy, respectively. Compared with cryotherapy, complete remission was observed with fewer immunotherapy sessions (2.17 ± 0.65 versus 3.82 ± 2.481), but there was no statistically significant difference between the groups (P = 0.051). Immunotherapy was well tolerated, apart from the most common side effect of pain during injection.

"Intralesional immunotherapy is an effective treatment of warts," the authors write. "This method has a better therapeutic response, needs fewer sessions, and is capable of treating distant warts."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »